Sign in

NCT07498894Completed

Salivary and Serum Inflammatory Biomarkers in Diabetic Nephropathy by Periodontal Status

Salivary and Serum Inflammatory Biomarkers Based on Periodontal Status in Individuals With Diabetic Nephropathy

Source: ClinicalTrials.gov · Last updated 27 Mar 2026

Brief summary (registry, in English)

Chronic inflammation underlies the bidirectional relationship between diabetes and periodontitis, a process that may be further exacerbated in the presence of diabetic nephropathy. While the roles of inflammatory cytokines such as TNF-α and IL-10 in both periodontal tissue destruction and diabetes-related microvascular complications remain unclear, NGAL is recognized as a biomarker for diabetic nephropathy but its association with periodontal disease is not well established. This study aimed to comparatively evaluate salivary and serum levels of NGAL, TNF-α, and IL-10 according to different periodontal conditions in individuals with newly diagnosed diabetes and those with diabetic nephropathy.

Status (registry)
Completed
Study type
Observational
Enrollment
126 (actual)
First submitted
23 Mar 2026
Start date
10 Jun 2024
Primary completion date
12 Dec 2025
Lead sponsor
Pamukkale University
NCT number
NCT07498894

What you commit to

  • Study type: Observational
  • Participants enrolled: 126
  • From 10 Jun 2024 to the primary completion date, 12 Dec 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Use of systemic antibiotics or anti-inflammatory drugs within the 6 months prior to study enrollment
  • Periodontal treatment within the previous 6 months

Other illness

  • History of malignancy
  • Type 1 diabetes mellitus, gestational diabetes mellitus, or secondary diabetes mellitus

Other

  • Having fewer than 15 natural teeth
  • Pregnancy or lactation

Who the study is looking for

  • Newly diagnosed diabetes: Diagnosed with type 2 diabetes mellitus for less than 5 years and the absence of any diabetic vascular complications
  • Diabetic nephropathy: Urinary albumin-to-creatinine ratio \>30 mg/g

Age in the registry: 20 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Pamukkale University Faculty of Dentistry
Coordinator of this site? Confirm its status
DenizliTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.